US 10085974
Dosage and formulation
granted A61KA61K31/167A61K31/439
Quick answer
US patent 10085974 (Dosage and formulation) held by Almirall, S.A. expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Almirall, S.A.
- Grant date
- Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/167, A61K31/439, A61K31/46, A61K45/06